Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)

Henrik Maagensen; Sofie Hædersdal; Jesper Krogh; Torben Hansen; Filip Krag Knop; Anne Cathrine Baun Thuesen; Tina Vilsbøll

doi:10.1111/dme.15387

Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)

Henrik Maagensen, Sofie Hædersdal, Jesper Krogh, Torben Hansen, Filip Krag Knop, Anne Cathrine Baun Thuesen, Tina Vilsbøll^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

1 Downloads (Pure)

Original language	English
Article number	e15387
Journal	Diabetic Medicine
Volume	41
Issue number	10
Number of pages	4
ISSN	0742-3071
DOIs	https://doi.org/10.1111/dme.15387
Publication status	Published - 2024

Access to Document

10.1111/dme.15387Licence: CC BY-NC

FulltextFinal published version, 157 KBLicence: CC BY-NC

Cite this

@article{97fc19faf7734356b324c9f4bce1dd13,

title = "Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)",

author = "Henrik Maagensen and Sofie H{\ae}dersdal and Jesper Krogh and Torben Hansen and Knop, {Filip Krag} and Thuesen, {Anne Cathrine Baun} and Tina Vilsb{\o}ll",

year = "2024",

doi = "10.1111/dme.15387",

language = "English",

volume = "41",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)

AU - Maagensen, Henrik

AU - Hædersdal, Sofie

AU - Krogh, Jesper

AU - Hansen, Torben

AU - Knop, Filip Krag

AU - Thuesen, Anne Cathrine Baun

AU - Vilsbøll, Tina

PY - 2024

Y1 - 2024

U2 - 10.1111/dme.15387

DO - 10.1111/dme.15387

M3 - Letter

C2 - 38875310

SN - 0742-3071

VL - 41

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 10

M1 - e15387

ER -